193 related articles for article (PubMed ID: 16185723)
1. Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines.
Hilber B; Scholze P; Dorostkar MM; Sandtner W; Holy M; Boehm S; Singer EA; Sitte HH
Neuropharmacology; 2005 Nov; 49(6):811-9. PubMed ID: 16185723
[TBL] [Abstract][Full Text] [Related]
2. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
[TBL] [Abstract][Full Text] [Related]
3. A quantitative model of amphetamine action on the 5-HT transporter.
Sandtner W; Schmid D; Schicker K; Gerstbrein K; Koenig X; Mayer FP; Boehm S; Freissmuth M; Sitte HH
Br J Pharmacol; 2014 Feb; 171(4):1007-18. PubMed ID: 24251585
[TBL] [Abstract][Full Text] [Related]
4. Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.
Callaghan PD; Irvine RJ; Daws LC
Neurochem Int; 2005 Oct; 47(5):350-61. PubMed ID: 15979209
[TBL] [Abstract][Full Text] [Related]
5. Regulating the conducting states of a mammalian serotonin transporter.
Quick MW
Neuron; 2003 Oct; 40(3):537-49. PubMed ID: 14642278
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
Yamauchi Y; Izumi T; Unemura K; Uenishi Y; Nakagawa T; Kaneko S
Neurosci Lett; 2007 Nov; 428(2-3):72-6. PubMed ID: 17949903
[TBL] [Abstract][Full Text] [Related]
7. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
8. N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents.
Gobbi M; Funicello M; Gerstbrein K; Holy M; Moya PR; Sotomayor R; Forray MI; Gysling K; Paluzzi S; Bonanno G; Reyes-Parada M; Sitte HH; Mennini T
J Neurochem; 2008 Jun; 105(5):1770-80. PubMed ID: 18248615
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.
Larsen MB; Sonders MS; Mortensen OV; Larson GA; Zahniser NR; Amara SG
J Neurosci; 2011 Apr; 31(17):6605-15. PubMed ID: 21525301
[TBL] [Abstract][Full Text] [Related]
10. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
Mlinar B; Corradetti R
Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
[TBL] [Abstract][Full Text] [Related]
11. The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.
Sealover NR; Felts B; Kuntz CP; Jarrard RE; Hockerman GH; Lamb PW; Barker EL; Henry LK
Biochem Pharmacol; 2016 Nov; 120():46-55. PubMed ID: 27638414
[TBL] [Abstract][Full Text] [Related]
12. Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action.
Kortagere S; Fontana AC; Rose DR; Mortensen OV
Neuropharmacology; 2013 Sep; 72():282-90. PubMed ID: 23632081
[TBL] [Abstract][Full Text] [Related]
13. The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter.
Kern C; Erdem FA; El-Kasaby A; Sandtner W; Freissmuth M; Sucic S
J Biol Chem; 2017 Mar; 292(9):3603-3613. PubMed ID: 28104804
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters.
Pifl C; Nagy G; Berényi S; Kattinger A; Reither H; Antus S
J Pharmacol Exp Ther; 2005 Jul; 314(1):346-54. PubMed ID: 15831439
[TBL] [Abstract][Full Text] [Related]
15. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
16. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T
J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
[TBL] [Abstract][Full Text] [Related]
17. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
Rickli A; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
[TBL] [Abstract][Full Text] [Related]
18. Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter.
Scholze P; Zwach J; Kattinger A; Pifl C; Singer EA; Sitte HH
J Pharmacol Exp Ther; 2000 Jun; 293(3):870-8. PubMed ID: 10869387
[TBL] [Abstract][Full Text] [Related]
19. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.
Kittler K; Lau T; Schloss P
Eur J Pharmacol; 2010 Mar; 629(1-3):63-7. PubMed ID: 20006597
[TBL] [Abstract][Full Text] [Related]
20. Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study.
Sitte HH; Scholze P; Schloss P; Pifl C; Singer EA
J Neurochem; 2000 Mar; 74(3):1317-24. PubMed ID: 10693966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
